Home » Merck Releases Positive Data for New Diabetes Drug
Merck Releases Positive Data for New Diabetes Drug
Merck’s investigational once-weekly treatment for Type 2 diabetes significantly lowered blood sugar in a Phase IIb study compared with a placebo.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May